Giant Cell Tumors
Showing 9951 - 9975 of >10,000
Malignant Solid Tumor Trial in Kanto Region (ONO-4538)
Completed
- Malignant Solid Tumor
- ONO-4538
-
Kanto Region, Kanto, Japan(unnamed)
Sep 15, 2020
Mitapivat in Subjects With Sickle Cell Disease
Enrolling by invitation
- Sickle Cell Anemia
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical
Recruiting
- Hemoglobinopathy (Disorder)
- +2 more
- Haploidentical Hematopoietic Cell Transplantation
-
Saint Petersburg, FloridaJohns Hopkins All Children's Hospital
Sep 13, 2022
Glioblastoma Multiforme, Brain Tumors, Gastroesophageal Adenocarcinoma Trial in Lyon Cedex (68Ga-FF58)
Recruiting
- Glioblastoma Multiforme
- +3 more
-
Lyon Cedex, FranceNovartis Investigative Site
Aug 9, 2022
Liver Cirrhosis Trial in Kharkov (Autologous BM MSC)
Active, not recruiting
- Liver Cirrhosis
- Autologous BM MSC
-
Kharkov, UkraineInstitute of Bio-Stem Cell Rehabilitation
May 16, 2022
Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant
Recruiting
- Immune Deficiency Disorders
- +13 more
- Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
-
Saint Louis, MissouriWashington University
Apr 25, 2022
Skin Cancer, Mucosal Tumor of Oral Cavity, Soft Tissue Tumor Trial in Haifa (Radiation: Diffusing Alpha Radiation Emitters
Recruiting
- Skin Cancer
- +2 more
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
-
Haifa, IsraelRAMBAM Health Care Campus
Feb 16, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Nivolumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 31, 2022
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Breast Cancer, Advanced Melanoma Trial in Worldwide (CyPep-1,
Not yet recruiting
- Advanced Head and Neck Squamous Cell Carcinoma
- +2 more
- CyPep-1
- Pembrolizumab 25 MG/ML [Keytruda]
-
Pittsburgh, Pennsylvania
- +18 more
Nov 21, 2022
Measures (PROMs) in Adoptive Cell Therapy (ACT) Setting
Not yet recruiting
- Cancer
- (no location specified)
Feb 7, 2023
Lymphoma Trial in Berne (Brentuximab Vedotin, BeEAM Regimen)
Recruiting
- Lymphoma
- Brentuximab Vedotin
- BeEAM Regimen
-
Berne, SwitzerlandDepartment for Medical Oncology University Hospital/Inselspital
Feb 4, 2022
Malignant Bone Tumors Trial in Boston (Radiation (Surgical Arm), Radiation (Non-surgical Arm), Malignant Tumor Surgery)
Completed
- Malignant Bone Tumors
- Radiation (Surgical Arm)
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Nov 8, 2021
Anemia Severe Trial in Pittsburgh (HBOC-201)
Available
- Anemia Severe
- HBOC-201
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
May 16, 2022
Small-Cell Lung Cancer Trial in Worldwide (Durvalumab, AZD2811, Carboplatin)
Active, not recruiting
- Small-Cell Lung Cancer
- Durvalumab
- +4 more
-
Grand Rapids, Michigan
- +11 more
Apr 25, 2022
Cognitive Impairment, Hematologic Tumors, Hematopoietic Cell Transplant Trial in Birmingham (Lumosity, Lumosity (waitlist
Recruiting
- Cognitive Impairment
- +2 more
- Lumosity
- Lumosity (waitlist control)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Apr 25, 2022
Learn More About NTRK Gene Fusion Positive in Solid Tumor in
Not yet recruiting
- Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
- No Drug
-
Multiple Locations, JapanMany Locations
Mar 20, 2023
Locally Advanced or Metastatic Solid Tumors Trial in Groningen (MPDL3280A)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
-
Groningen, NetherlandsUniversity Medical Center Groningen
Feb 28, 2022
PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark
Recruiting
- Anal Cancer
-
Aarhus, Denmark
- +2 more
Oct 5, 2022
CD19+ and CD 22+ B-ALL Trial in Langfang (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells, Cyclophosphamide,Fludarabine)
Recruiting
- CD19+ and CD 22+ B-ALL
- Autologous CD19/CD22 Chimeric Antigen Receptor T-cells
- Cyclophosphamide,Fludarabine
-
Langfang, Hebei, ChinaHebei Yanda Ludaopei Hospital
Jan 25, 2022
Chronic Kidney Disease, Congenital Anomalies of Kidney and Urinary Tract Trial in United States (Renal Autologous Cell Therapy
Recruiting
- Chronic Kidney Disease
- Congenital Anomalies of Kidney and Urinary Tract
- Renal Autologous Cell Therapy (REACT®)
-
Meridian, Idaho
- +5 more
Mar 9, 2022
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)
Recruiting
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Imatinib
- +3 more
-
Frankfurt, GermanyDepartment of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023
White Blood Cells Engulfing Red Blood Cells Trial in Brussel (No intervention, observational study)
Recruiting
- White Blood Cells Engulfing Red Blood Cells
- No intervention, observational study
-
Brussel, BelgiumUZ Brussel
Jan 30, 2023
BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)
Recruiting
- Renal Cancer Metastatic
- Immunological and tumour characterization
-
Lyon, FranceCentre Leon Berard
Mar 14, 2022